During or very soon after the 1990–1991 Persian Gulf War, veterans of the conflict began to report symptoms of illness. Common complaints included combinations of cognitive difficulties, fatigue, myalgia, rashes, dyspnea, insomnia, gastrointestinal symptoms and sensitivity to odors. Gradually in the USA, and later in the UK, France, Canada, Denmark and Australia, governments implemented medical assessment programs and epidemiologic studies to determine the scope of what was popularly referred to as “the Gulf War syndrome”. Attention was drawn to numerous potentially toxic deployment-related exposures that appeared to vary by country of deployment, by location within the theater, by unit, and by personal job types. Identifying a single toxicant cause was considered unlikely and it was recognized that outcomes were influenced by genetic variability in xenobiotic metabolism.
Derived from primary papers and key reports by the Research Advisory Committee on Gulf War Veterans’ Illnesses and the Institute of Medicine, a brief overview is presented of war related events, symptoms and diagnostic criteria for Gulf War illness (GWV), some international differences, the various war-related exposures and key epidemiologic studies. Possible exposure interactions and pathophysiologic mechanisms are discussed.
Exposures to pyridostigmine bromide, pesticides, sarin and mustard gas or combinations thereof were most associated with GWI, especially in some genotype subgroups. The resultant oxidant stress and background exposome must be assumed to have played a role.
Gulf War (GW) exposures and their potential toxic effects should be considered in the context of the human genome, the human exposome and resultant oxidant stress to better characterize this unique environmentally-linked illness and, ultimately, provide a rationale for more effective interventions and future prevention efforts.
Fukuda K, Nisenbaum R, Stewart G, Thompson WW, Robin L, et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. J Am Med Assoc 1998;280(11):981–8.
Steele L. Prevalence and patterns of Gulf War illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service. Am J Epidemiol 2000;152(10):992–1002.
Kang HK, Mahan CM, Lee KY, Magee CA, Murphy FM. Illnesses among United States veterans of the Gulf War: a population-based survey of 30,000 veterans. J Occup Environ Med 2000;42(5):491–501.
Kang HK, Li B, Mahan CM, Eisen SA, Engel CC. Health of US veterans of 1991 Gulf War: a follow-up survey in 10 years. J Occup Environ Med 2009;51(4):401–10.
Ozakinci G, Hallman WK, Kipen HM. Persistence of symptoms in veterans of the First Gulf War: 5-year follow-up. Environ Health Perspect 2006;114(10):1553–7.
Hotopf M, David AS, Hull L, Nikalaou V, Unwin C, et al. Gulf War illness – better, worse, or just the same? A cohort study. Br Med J 2003;327(7428):1370–2A.
Gavaghan H. NIH panel rejects Persian Gulf syndrome. Nature 1994;369(6475):8.
Robinson A. Veterans worry that unexplained medical problems a legacy of service during Gulf-War. Can Med Assoc J 1995;152(6):944–7.
Research Advisory Committee on Gulf War Veterans’ Illnesses. Gulf War Illness and the Health of Gulf War Veterans. Scientific Findings and Recommendations. Washington, DC: U.S. Government Printing Office, 2008.
Goss Gilroy Inc. Health Study of Canadian Forces Personnel Involved in the 1991 Conflict in the Persian Gulf. In: Department of National Defence, editor. Ottawa Canada: Gulf War illness Advisory Committtee, 1998.
Institute of Medicine. Gulf War and Health: Volume 4. Health Effects of Serving in the Gulf War. Washington, DC: The National Academies Press, 2006:292p.
Gavaghan H. NIH panel rejects Persian-Gulf syndrome. Nature 1994;369(6475):8.
Institute of Medicine. Chronic Multisymptom Illness in Gulf War Veterans: Case Definitions Reexamined. Washington, DC: The National Academies Press, 2014:130p.
Haley RW, Kurt TL, Hom J. Is there a Gulf War syndrome? Searching for syndromes by factor analysis of symptoms. J Am Med Assoc 1997;277(3):215–22.
Iannacchione VG, Dever JA, Bann CM, Considine KA, Creel D, et al. Validation of a research case definition of Gulf War illness in the 1991 US military population. Neuroepidemiology 2011;37(2):129–40.
Haley RW, Tuite JJ. Epidemiologic evidence of health effects from long-distance transit of chemical weapons fallout from bombing early in the 1991 Persian Gulf War. Neuroepidemiology 2013;40(3):178–89.
Justice delayed: acknowledging the reality of Gulf War illness. Lancet 2008;372(9653):1856.
Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 2003;11(1):7–115.
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121(12):953–9.
Jason LA, Brown A, Evans M, Sunnquist M, Newton JL. Contrasting chronic fatigue syndrome versus myalgic encephalomyelitis/chronic fatigue syndrome. Fatigue 2013;1(3):168–83.
Reeves WC, Jones JF, Maloney E, Heim C, Hoaglin DC, et al. Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul Health Metr 2007;5:5.
Reyes M, Nisenbaum R, Hoaglin DC, Unger ER, Emmons C, et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med 2003;163(13):1530–6.
Eisen SA, Kang HK, Murphy FM, Blanchard MS, Reda DJ, et al. Gulf war veterans’ health: Medical evaluation of a US cohort. Ann Intern Med 2005;142(11):881–90.
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, et al. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62(5):600–10.
Meggs WJ. Gulf War syndrome, chronic fatigue syndrome, and the multiple chemical sensitivity syndrome: stirring the cauldron of confusion. Arch Environ Health 1999;54(5):309–11.
Bartha L, Baumzweiger W, Buscher DS, Callender T, Dahl KA, et al. Multiple chemical sensitivity: A 1999 consensus. Arch Environ Health 1999;54(3):147–9.
Kutsogiannis DJ, Davidoff AL. A multiple center study of multiple chemical sensitivity syndrome. Arch Environ Health 2001;56(3):196–207.
Kipen HM, Hallman W, Kang H, Fiedler N, Natelson BH. Prevalence of chronic fatigue and chemical sensitivities in Gulf Registry Veterans. Arch Environ Health 1999;54(5):313–8.
Black DW, Doebbeling BN, Voelker MD, Clarke WR, Woolson RF, et al. Multiple chemical sensitivity syndrome – Symptom prevalence and risk factors in a military population. Arch Intern Med 2000;160(8):1169–76.
Proctor SP, Heaton KJ, White RF, Wolfe J. Chemical sensitivity and chronic fatigue in Gulf War veterans: A brief report. J Occup Environ Med 2001;43(3):259–64.
Gray GC, Reed RJ, Kaiser KS, Smith TC, Gastanaga VM. Self-reported symptoms and medical conditions among 11,868 Gulf War-era veterans. Am J Epidemiol 2002;155(11):1033–44.
Fiedler N, Giardino N, Natelson B, Ottenweller JE, Weisel C, et al. Responses to controlled diesel vapor exposure among chemically sensitive Gulf War veterans. Psychosom Med 2004;66(4):588–98.
Miller CS, Prihoda TJ. A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients and persons with multiple chemical sensitivity. Toxicol Ind Health 1999;15(3–4):386–97.
Reid S, Hotopf M, Hull L, Ismail K, Unwin C, et al. Multiple chemical sensitivity and chronic fatigue syndrome in British Gulf War veterans. Am J Epidemiol 2001;153(6):604–9.
Reid S, Hotopf M, Hull L, Ismail K, Unwin C, et al. Reported chemical sensitivities in a health survey of United Kingdom military personnel. Occup Environ Med 2002;59(3):196–8.
Haley RW, Billecke S, La Du BN. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol 1999;157(3):227–33.
McKeown-Eyssen G, Baines C, Cole DE, Riley N, Tyndale RF, et al. Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR. Int J Epidemiol 2004;33(5):971–8.
Salamon R, Verret C, Jutand MA, Begassat M, Laoudj F, et al. Health consequences of the first Persian Gulf War on French troops. Int J Epidemiol 2006;35(2):479–87.
Upshall DG. Gulf related illness–current perspectives. J R Army Med Corps 2000;146(1):13–7.
Proctor SP, Heeren T, White RF, Wolfe J, Borgos MS, et al. Health status of Persian Gulf War veterans: self-reported symptoms, environmental exposures and the effect of stress. Int J Epidemiol 1998;27(6):1000–10.
Wolfe J, Proctor SP, Davis JD, Borgos MS, Friedman MJ. Health symptoms reported by Persian Gulf War veterans two years after return. Am J Ind Med 1998;33(2):104–13.
Kang HK, Mahan CM, Lee KY, Murphy FM, Simmens SJ, et al. Evidence for a deployment-related Gulf War syndrome by factor analysis. Arch Environ Health 2002;57(1):61–8.
Blanchard MS, Eisen SA, Alpern R, Karlinsky J, Toomey R, et al. Chronic multisymptom illness complex in Gulf War I veterans 10 years later. Am J Epidemiol 2006;163(1):66–75.
LaClair B, editor. Overview of Exposures and HEalth Conditions Reported by Countries who served in the 1990–1991 Gulf War Allied Coalition. RAC-GWVI Meeting Minutes. Washington, DC: U.S. Government Printing Office, 2005.
Unwin C, Blatchley N, Coker W, Ferry S, Hotopf M, et al. Health of UK servicemen who served in Persian Gulf War. Lancet 1999;353(9148):169–78.
Ismail K, Everitt B, Blatchley N, Hull L, Unwin C, et al. Is there a Gulf War syndrome? Lancet 1999;353(9148):179–82.
Unwin C, Hotopf M, Hull L, Ismail K, David A, et al. Women in the Persian Gulf: Lack of gender differences in long term health effects of service in United Kingdom armed forces in the 1991 Persian Gulf War. Mil Med 2002;167(5):406–13.
Cherry N, Creed F, Silman A, Dunn G, Baxter D, et al. Health and exposures of United Kingdom Gulf war veterans. Part II: The relation of health to exposure. Occup Environ Med 2001;58(5):299–306.
Tuite JJ, Haley RW. Meteorological and intelligence evidence of long-distance transit of chemical weapons fallout from bombing early in the 1991 Persian Gulf War. Neuroepidemiology 2013;40(3):160–77.
Sim M, Kelsall H. Gulf War illness: a view from Australia. Philos Trans R Soc Lon B Biol Sci 2006;361(1468):619–26.
Kelsall HL, Sim MR, Forbes AB, Glass DC, McKenzie DP, et al. Symptoms and medical conditions in Australian veterans of the 1991 Gulf War: relation to immunisations and other Gulf War exposures. Occup Environ Med 2004;61(12):1006–13.
Ishoy T, Suadicani P, Guldager B, Appleyard M, Gyntelberg F. Risk factors for gastrointestinal symptoms. The Danish Gulf War Study. Dan Med Bull 1999;46(5):420–3.
Suadicani P, Ishoy T, Guldager B, Appleyard M, Gyntelberg F. Determinants of long-term neuropsychological symptoms – The Danish Gulf War Study. Dan Med Bull 1999;46(5):423–7.
Specter A. Report of the special investigation unit on Gulf War illnesses. In: Senate CoVAUS, editor. Washington, DC: U.S. Government Printing Office, 1998.
Gackstetter GD, Hooper TI, Al Qahtani MS, Smith TC, Memish ZA, et al. Assessing the potential health impact of the 1991 Gulf War on Saudi Arabian National Guard Soldiers. Int J Epidemiol 2005;34(4):801–8.
Cope SE, Schultz GW, Richards AL, Savage HM, Smith GC, et al. Assessment of arthropod vectors of infectious diseases in areas of US Troop deployment in the Persian Gulf. Am J Trop Med Hyg 1996;54(1):49–53.
Gordon JJ, Inns RH, Johnson MK, Leadbeater L, Maidment MP, et al. The delayed neuropathic effects of nerve agents and some other organo-phosphorus compounds. Arch Toxicol 1983;52(2):71–82.
Soltaninejad K, Abdollahi M. Current opinion on the science of organophosphate pesticides and toxic stress: a systematic review. Med Sci Monit 2009;15(3):RA75–90.
Terry AV, Jr. Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms. Pharmacol Ther 2012;134(3):355–65.
Kaufer D, Friedman A, Seidman S, Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 1998;393(6683):373–7.
Sanborn M, Kerr KJ, Sanin LH, Cole DC, Bassil KL, et al. Non-cancer health effects of pesticides – Systematic review and implications for family doctors. Can Fam Physician 2007;53:1713–20.
Khan F, Kennedy G, Spence VA, Newton DJ, Belch JJ. Peripheral cholinergic function in humans with chronic fatigue syndrome, Gulf War syndrome and with illness following organophosphate exposure. Clin Sci (Lond) 2004;106(2):183–9.
Golomb BA. Acetylcholinesterase inhibitors and Gulf War illnesses. Proc Natl Acad Sci USA 2008;105(11):4295–300.
Barr DB, Angerer J. Potential uses of biomonitoring data: A case study using the organophosphorus pesticides chlorpyrifos and malathion. Environ Health Perspect 2006;114(11):1763–9.
Centers for Disease Control and Prevention. Third National Report on Human Exposure to Environmental Chemicals. Atlanta (GA): CDC, 2005.
Brimfield AA. Chemicals of military deployments: revisiting Gulf War syndrome in light of new information. Prog Mol Biol Transl Sci 2012;112:209–30.
Dacre JC, Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev 1996;48(2):289–326.
Defense Science Board:. Report of the Defense Science Board Task Force on Persian Gulf War Health Effects. 1994. Available from: http://www.gulflink.osd.mil/dsbrpt/warfare.html. Accessed on 16 September, 2015.
Golomb BA. A Review of the scientific literature as it pertains to Gulf War illnesses: volume 2: pyridostigmine bromide. Santa Monica, CA: RAND Corporation, 1999.
Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. Organochlorine insecticides in substantia nigra in Parkinson’s disease. J Toxicol Environ Health A 2000;59(4):229–34.
Reuveni H, Yagupsky P. Diethyltoluamide – containing insect repellent – adverse-effects in worldwide USE. Arch Dermatol 1982;118(8):582–3.
Hon Z, Oesterreicher J, Navratil L. Depleted Uranium and its effects on humans. Sustainability 2015;7(4):4063–77.
McDiarmid MA, Gaitens JM, Hines S, Condon M, Roth T, et al. Biologic monitoring and surveillance results for the department of veterans affairs’ depleted uranium cohort: lessons learned from sustained exposure over two decades. Am J Ind Med 2015;58(6):583–94.
Abou-Donia MB, Dechkovskaia AM, Goldstein LB, Abdel-Rahman A, Bullman SL, et al. Co-exposure to pyridostigmine bromide, DEET, and/or permethrin causes sensorimotor deficit and alterations in brain acetylcholinesterase activity. Pharmacol Biochem Behav 2004;77(2):253–62.
Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, et al. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med 1996;2(12):1382–5.
Tomkins O, Kaufer D, Korn A, Slielef I, Golan H, et al et al. Frequent blood-brain barrier disruption in the human cerebral cortex. Cell Mol Neurobi 2001;21(6):675–91.
Heller JM, Legge WE. Final report kuwait oil fire health risk assessment. In: Army, editor. Aberdeen Proving Ground, Maryland, 1991.
Lorber M, Gibb H, Grant L, Pinto J, Pleil J, et al. Assessment of inhalation exposures and potential health risks to the general population that resulted from the collapse of the World Trade Center towers. Risk Anal 2007;27(5):1203–21.
Schecter A, Birnbaum L, Ryan JJ, Constable JD. Dioxins: an overview. Environ Res 2006;101(3):419–28.
Frederiksen M, Vorkamp K, Thomsen M, Knudsen LE. Human internal and external exposure to PBDEs – A review of levels and sources. Int J Hyg Environ Health 2009;212(2):109–34.
Hill AB. Environment and disease – association or causation. Proc R Soc Med 1965;58(5):295–300.
Steele L, Lockridge O, Gerkovich MM, Cook MR, Sastre A. Butyrylcholinesterase genotype and enzyme activity in relation to Gulf War illness: preliminary evidence of gene-exposure interaction from a case-control study of 1991 Gulf War veterans. Environ Health 2015;14:4.
Gradin VB, Perez A, MacFarlane JA, Cavin I, Waiter G, et al. Abnormal brain responses to social fairness in depression: an fMRI study using the Ultimatum Game. Psychol Med 2015;45(6):1241–51.
Iversen A, Chalder T, Wessely S. Gulf war illness: Lessons from medically unexplained symptoms. Clinical Psychol Rev 2007;27(7):842–54.
Ismail K, Kent K, Brugha T, Hotopf M, Hull L, et al. The mental health of UK Gulf war veterans: phase 2 of a two phase cohort study. Br Med J 2002;325(7364):576–9.
Institute of Medicine. Gulf War and Health: Volume 8: Update of Health Effects of Serving in the Gulf War. Washington, DC: The National Academies Press, 2010. p. 320.
Research Advisory Committee on Gulf War Veterans’ Illnesses. Gulf War Illness and the Health of Gulf War Veterans: Research Update and Recommendations, 2009–2013. Boston, MA: U.S. Government Printing Office, 2014.
Baraniuk JN, El-Amin S, Corey R, Rayhan R, Timbol C. Carnosine treatment for gulf war illness: a randomized controlled trial. Glob J Health Sci 2013;5(3):69–81.
Golomb BA, Allison M, Koperski S, Koslik HJ, Devaraj S, et al. Coenzyme Q10 benefits symptoms in Gulf War veterans: results of a randomized double-blind study. Neural Comput 2014;26(11):2594–651.
Hodgson E, Rose RL. Human metabolism and metabolic interactions of deployment-related chemicals. Drug Metab Rev 2005;37(1):1–39.
She Z-G, Chen H-Z, Yan Y, Li H, Liu D-P. The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid Redox Signal 2012;16(6):597–632.
Rose RL, Tang J, Choi J, Cao Y, Usmani A, et al. Pesticide metabolism in humans, including polymorphisms. Scand J Work Environ Health 2005;31:156–63.
De Luca C, Gugliandolo A, Calabro C, Curro M, Ientile R, et al. Role of polymorphisms of inducible nitric oxide synthase and endothelial nitric oxide synthase in idiopathic environmental intolerances. Mediators Inflamm 2015;2015:245308.
Kroenke K, Koslowe P, Roy M. Symptoms in 18,495 Persian Gulf War veterans – Latency of onset and lack of association with self-reported exposures. J Occup Environ Med 1998;40(6):520–8.
Brimfield AA, Mancebo AM, Mason RP, Jiang JJ, Siraki AG, et al. Free radical production from the interaction of 2-chloroethyl vesicants (mustard gas) with pyridine nucleotide-driven flavoprotein electron transport systems. Toxicol Appl Pharmacol 2009;234(1):128–34.
Brimfield AA, Soni SD, Trimmer KA, Zottola MA, Sweeney RE, et al. Metabolic activation of sulfur mustard leads to oxygen free radical formation. Free Radic Biol Med 2012;52(4):811–7.
Centers for Disease Control and Prevention. Recognition of Illness Associated With Exposure to Chemical Agents – United States, 2003. Morbidity and Mortality Weekly Report: U.S. Department of Health and Human Services, 2003:938–40.
Carpenter DO, Arcaro K, Spink DC. Understanding the human health effects of chemical mixtures. Environ Health Perspect 2002;110:25–42.
De Rosa CT, El-Masri HA, Pohl H, Cibulas W, Mumtaz MM. Implications of chemical mixtures in public health practice. J Toxicol Environ Health B Crit Rev 2004;7(5):339–50.
Needham LL, Barr DB, Calafat AM, editors. Characterizing children’s exposures: beyond NHANES2004 Feb 10–14; Honolulu, HI.
Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012;41(1):24–32.
Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2005;14(8):1847–50.
Rappaport SM, Smith MT. Epidemiology. Environment and disease risks. Science 2010;330(6003):460–1.
Sexton K. Cumulative risk assessment: an overview of methodological approaches for evaluating combined health effects from exposure to multiple environmental stressors. Int J Environ Res Public Health 2012;9(2):370–90.
©2015 Walter de Gruyter GmbH, Berlin/Boston.
